Literature DB >> 8215925

Cysticercosis of the central nervous system and cerebrospinal fluid. Immunodiagnosis of 1573 patients in 63 years (1929-1992).

A Spina-França1, J A Livramento, L R Machado.   

Abstract

Attention given to prophylaxis of neurocysticercosis (NC) is far beyond minimal needs among several regions of the in-development world, and for this reason incidence of the disease persists high among them. This investigation was carried out to show the extent of the problem by analysing the incidence of NC in a region of Brazil (São Paulo). CSF immunodiagnosis of NC by detecting antibodies to Cysticercus cellulosae in a neurodiagnostics laboratory is evaluated for this purpose. Cases studied in a 63-year period (1929-1992) are reviewed. Total cases in this period is 139,000, and for 1,573 (1.13%) diagnosis is NC. Special characteristics were not detected for colour and sex prevalence. Age bracket prevalence is from 21 to 40 years old (55.3%) high rates occurring for women between 21 to 30 years old, and for men between 31 to 40. Cases distribution in five consecutive decades (1942-1991) shows no decreasing tendency: average incidence is 1% for the 50 years, and it is over this average for the last three decades. Data confirm that incidence continues expressively high throughout the 50 years covered by this study.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8215925     DOI: 10.1590/s0004-282x1993000100003

Source DB:  PubMed          Journal:  Arq Neuropsiquiatr        ISSN: 0004-282X            Impact factor:   1.420


  2 in total

1.  Antigen-specific suppression of cultured lymphocytes from patients with neurocysticercosis.

Authors:  E C Bueno; A J Vaz; L R Machado; J A Livramento; S L Avila; A W Ferreira
Journal:  Clin Exp Immunol       Date:  2001-11       Impact factor: 4.330

2.  Serodiagnosis of human cysticercosis by using antigens from vesicular fluid of Taenia crassiceps cysticerci.

Authors:  E C Bueno; M Snege; A J Vaz; P G Leser
Journal:  Clin Diagn Lab Immunol       Date:  2001-11
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.